Abstract
Soluble endoglin exacerbates bile acid retention during labetalol treatment in mice with ethinylestradiol-induced cholestasis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.atherosclerosis.2023.06.247
Copy DOIJournal: Atherosclerosis | Publication Date: Aug 1, 2023 |
Soluble endoglin exacerbates bile acid retention during labetalol treatment in mice with ethinylestradiol-induced cholestasis
Join us for a 30 min session where you can share your feedback and ask us any queries you have